Year: 2012
Type: article
Abstract: In March 2011, the Acromegaly Consensus Group met to revise and update the guidelines on the diagnosis and treatment of acromegaly complications. The meeting was sponsored by the Pituitary Society and the European Neuroendocrinology Association and included experts skilled in the management of acromegaly. Complications considered included cardiovascular, endocrine and metabolic, sleep apnea, bone diseases, and mortality. Outcomes in selected, related clinical conditions were also considered, and included pregnancy, familial acromegaly and invasive macroadenomas. The need for a new disease staging model was considered, and design of such a tool was proposed.
Source: Pituitary
Institutions: Cedars-Sinai Medical Center, Universidade de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago, Harvard University, Massachusetts General Hospital, Universidade de São Paulo, Université Paris-Sud, Inserm, Assistance Publique – Hôpitaux de Paris, Bicêtre Hospital, Erasmus MC, Charité – Universitätsmedizin Berlin, Churchill Hospital, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Brescia
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,490
OpenAlex ID: W2126573384